1. The effect of lisuride hydrogen-maleate in the hyperprolactinemia-amenorrhea syndrome: clinical and hormonal responses;Cecco;Clin. Endocrinol. (Oxf.),1978
2. The inhibition of prolactin secretion in man by CB-154 (2-Br-α-ergocriptine);Pozo;J. clin. Endocrinol. Metab.,1972
3. Di Salle , E. Giudici , D. Ornati , G. Carfagna , N. Caccia , C. Moretti , A. Pegrassi , L. Rossi , A. 1984a Prolactin lowering and central dopaminergic activities of the new ergoline derivative FCE 21336 in vivo and in vitro in the rat Proceedings of the First European Neuroendocrine Association , Basel, 4′7 March, Abstract Volume 122
4. FCE 21336, a new ergoline derivative with a potent and long-acting lowering effect on prolactin secretion in rats;Salle;J. Endocrinol. Invest.,1982
5. Confronto della durata dell effetto inibitorio sulla secrezione di prolattina in vivo ed in vitro nel ratto da parte di FCE 21336, pergolide e bromocriptina;Salle;J. Endocrincol. Invest.,1984b